Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Chronic kidney disease (CKD) is a progressive disease characterized by irreversible loss of kidney function for more than 3 months. Once CKD progresses to stage 5, there is an increased risk of complications, with patients requiring renal replacement therapy. Following the initiation of hemodialysis, there is increased risk of readmissions and mortality in the first 90 days.
This study aimed to study the clinical profile of CKD stage 5 patients initiated on hemodialysis at Tribhuvan University Teaching Hospital (TUTH) and examine 90-day outcomes.
This prospective descriptive observational study was conducted on 171 adult patients with CKD stage 5 initiated on hemodialysis. Patients' demographic data, comorbidities, vascular access, and laboratory parameters were recorded. Descriptive and inferential statistics including chi-square, independent t-test, and Mann-Whitney U test were applied according to the variable types to evaluate associations.
Mean age of the participants was 48.76±16.61 years with 68.4% of participants being males. Hypertension was seen in 81% of the participants. Chronic glomerulonephritis was found to be the most common (in 45%) cause of CKD. The most common symptom was uremic gastropathy in 59.1%. Temporary femoral dialysis catheter was the most common dialysis access in 50.3% of the participants. Anemia was present in 98.8% of the participants.
Within the first 90 days of starting hemodialysis, 17 (9.94%) patients died. In the same period, 31.36% of patients were readmitted. Smokers, 50 years and older and those with cardiac comorbidities were found to have significant statistical association with 90-day mortality following initiation of hemodialysis.
Following hemodialysis for CKD stage 5, there is a high risk of hospital readmission and mortality in the subsequent 90 days. Smoking, ageing, and cardiac dysfunction are risk factors for increased mortality in this period.
